FDA
approval
· 2025-01-27
FDA Approved: MOXIFLOXACIN OPHTHALMIC SOLUTION — Original Application (Lifestar Pharma LLC)
Summary
FDA approved a generic ophthalmic moxifloxacin solution from Lifestar Pharma LLC under an original ANDA for the treatment of bacterial conjunctivitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for MOXIFLOXACIN OPHTHALMIC SOLUTION (MOXIFLOXACIN)